Catalyst Wire Dossier Catalyst Wire Dossier

Brimonidine tartrate 0.2% / Timolol maleate 0.5% fixed combination

brimonidine tartrate; timolol maleate · Allergan
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Brimonidine tartrate 0.2% / Timolol maleate 0.5% fixed combination, covering 2011-09-21 to 2011-09-21. Get the full timeline:

Most recent: Clinical Trial Update: An Evaluation of the Fixed Combination Brimonidine Tartrate 0.2%/ Timolol Maleate 0.5% to Latanoprost 0.005% in Glaucoma or Ocular Hypertension Subjects [Phase 4]

See pricing